Newsroom

Recent News Releases

May 17th, 202305/17/2023

U.S. Food & Drug Administration Grants Priority Review of TAK-755 for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

May 11th, 202305/11/2023

Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in 2023

May 11th, 202305/11/2023

Takeda Delivers Strong Revenue and Profit Growth in FY2022 Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook

May 9th, 202305/09/2023

Takeda Awarded Top Honors in Social Impact Category for the 2023 ISPE Facility of the Year Awards

May 1st, 202305/01/2023

Takeda to Hold Fourth Quarter and Full-Year FY2022 Earnings Call on May 11

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via [email protected]. If you generally would like to contact us, please visit Contact Us.

Newsroom

Recent News Releases

Featured Topics

Luck is not a strategy: The world needs to start preparing now for the next pandemic

The COVID-19 Mental Burden on Working Mothers

Takeda Neuroscience at AAN 2021 Data Demonstrates Positive Progress of Key Homegrown Assets TAK-925 and TAK-935 soticlestat

Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

In the News

Executive Leadership